Pharmacokinetics and bioequivalence of doxycycline (Providox® and Doxyvet 0-50 S®) oral powder formulations in chickens

International Journal of Poultry Science

Volumn 7, Issue 2, 2008, Pages 161-164

  Hantash, Tariq M ^a   Abu Basha, Ehab A ^b   Roussan, Dergham A ^a   Abudabos, Alaeldein M ^c  

^a Provimi Jordan   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c MUTAH UNIVERSITY   (Jordan)

Author keywords

Bioavailability; Bioequivalence; Chicken; Doxycycline and pharmacokinetics

Indexed keywords

GALLUS GALLUS;

EID: 41449116396     PISSN: 16828356     EISSN: None     Source Type: Journal    
DOI: 10.3923/ijps.2008.161.164     Document Type: Article

References (22)

1. Abd El-Aty, A.M., A. Goudaha and H.H. Zhoub, 2004. Pharmacokinetics of doxycycline after administration as a single intravenous bolus and intramuscular doses to non-lactating Egyptian goats. Pharmacol. Res., 49: 487-491.
2. Anadon, A., M. Larranaga, M. Diaz, P. Bringas, M. Fernandez, M. Cruz, J. Iturbe and M. Martinez, 1994. Pharmacokinetics of doxycycline in broiler chickens. Avian Pathol., 23: 79-90.
3. Aronson, A.L., 1980. Pharmacotherapeutics of the newer tetracyclines. J. Am. Vet. Med. Assoc., 176: 1061-1068.
4. Axisa, B., A.R. Naylor, P.R. Bell and M.M. Thompson, 2000. Simple and reliable method of doxycycline determination in human plasma and biological tissues. J. Chromatog. B. Biomed. Appl., 744: 359-365.
5. Baert, K., S. Croubels, F. Gasthuys, J. Busser and P. Backer, 2000. Pharmacokineticsand oral Bioavailability of a doxycycline formulation (doxycycline 75%) in non- fasted young pigs. J. Vet. Pharmacol. Ther., 23: 45-48.
6. Bryant, J., M. Brown, R. Gronwall and K. Merritt, 2000. Study of intragastric administration of doxycycline pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine Vet. J., 32: 233-238.
7. Chen, M.L., V. Shah, R. Patnaik, W. Adams, A. Hussain, D. Conner, M. Mehta, H. alinowski, J. Lazor, S.M. Huang, D. Hare, L. Lesko, D. Sporn and R. Williams, 2001. Bioavailability and bioequivalence: An FDA regulatory overview. Pharmaceutical Res., 18: 1645-1650.
8. Croubels, S., K. Baert, J. Busser and P. De Backer, 1998. Residue study of doxycycline and 4-epidoxycycline in pigs medicated via drinking water. Analyst, 123: 2733-2736.
9. Gibaldi, M. and D. Perrier, 1982. Non-compartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd Edn. Marcel Dekker, New York, USA., pp: 409-417.
10. Goren, E., W.A. De-Jong, P. Doornenbal and T. Laurense, 1998. Therapeutic efficacy of doxycycline hyclate in expermintal Escherichia coli infection in broilers. Vet. Q., 10: 48-52.
11. Hoelscher, A.A., J.K. Bahcall and J.S. Maki, 2006. In vitro evaluation of the antimicrobial effects of a root canal sealer-antibiotic combination against Enterococcus faecalis. J. Endod., 32: 145-147.
12. Ismail, M.M. and Y.A. El-Kattan, 2004. Disposition kinetics of doxycycline in chickens naturally infected with Mycoplasma gallisepticum. Br. Poult. Sci., 45: 550-556.
13. Jha, V., C. Jayachandran, M. Singh and S. Singh, 1989. Pharmacokinetic data on doxycycline and its distribution in different biological fluids in female goats. Vet. Res. Commun., 13: 11-16.
14. Laczay, P., G. Semjen, J. Lehel and G. Nagy, 2001. Pharmacokinetics and bioavailability of doxycycline in fasted and nonfasted broiler chickens. Acta Vet. Hung., 49: 31-37.
15. Martinez, M.N. and J.E. Riviere, 1994. Review of the 1993. Veterinary drug bioequivalence workshop, J. Vet. Pharmacol. Ther., 17: 85-119.
16. Moskowitz, S.M., J.M. Foster, J. Emerson and J.L. Burns, 2004. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol., 42: 1915-22.
17. Prats, C., G. Elkorchi, M. Giralt, C. Cristofol, J. Pena, I. Zorrilla, J. Saborit and B. Perez, 2005. PK and PK/PD of doxycycline in drinking water after therapeutic use in pigs. J. Vet. Pharmacol. Ther., 28: 525-530.
18. Riond, J.L. and J.E. Riviere, 1990. Pharmacokinetics and metabolic inertness of doxycycline in young pigs. Am. J. Vet. Res., 51: 1271-1275.
19. Santos, M.D., H. Vermeersch, J.P. Remon, M. Schelkens, P. De Backer, H.J. Van Bree, R. Ducatelle and F. Haesebrouck, 1996. Pharmacokinetics and bioavailability of doxycycline in turkeys. J. Vet. Pharmacol. Ther., 19: 274-280.
20. Takahashi, I. and T. Yoshida, 1989. Antimycoplasmal activities of ofloxacin and commonly used antimicrobial agents on Mycoplasma gallisepticum. Jp. J. Antibio., 5: 1166-1172.
21. Toutain, P.L. and A. Bousquet-Melou, 2004. Bioavailability and its assessment. J. Pharmacol. Therap., 27: 455-466.
22. Waites, K.B., D.M. Crabb and L.B. Duffy, 2003. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents. Chemother., 47: 3973-3975.